Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 80, 2020 - Issue 8
Submit an article Journal homepage
103
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Prognostic utility of serum YKL-40 in patients with cervical cancer

Anne Roslinda Department of Pathology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, DenmarkView further author information
,
Connie Palleb Department of Gynecology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, DenmarkView further author information
,
Julia Sidenius Johansenc Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark;d Department of Medicine, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark;e Institute of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DenmarkView further author information
,
Ib Jarle Christensenf Department of Surgical Gastroenterology, Hvidovre Hospital, Copenhagen University Hospital, Copenhagen, DenmarkView further author information
,
Hans Jørgen Nielsene Institute of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;f Department of Surgical Gastroenterology, Hvidovre Hospital, Copenhagen University Hospital, Copenhagen, DenmarkView further author information
&
Berit Jul Mosgaardb Department of Gynecology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark;g Department of Gynecology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, DenmarkCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3043-6986View further author information
ORCID Icon
Pages 687-693 | Received 12 May 2020, Accepted 01 Nov 2020, Published online: 13 Nov 2020

References

  • Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–1953.
  • Karki R, Kanneganti TD. Diverging inflammasome signals in tumorigenesis and potential targeting. Nat Rev Cancer. 2019;19(4):197–214.
  • Szewczyk G, Maciejewski TM, Szukiewicz D. Current progress in the inflammatory background of angiogenesis in gynecological cancers. Inflamm Res. 2019;68(4):247–260.
  • Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674.
  • Yeo IJ, Chong-Kil L, Han SB. Roles of chitinase 3-like 1 in the development of cancer, neurodegenerative diseases, and inflammatory diseases. Rev Pharmacol Ther. 2019;203:107394.
  • Kzhyshkowska J, Yin S, Liu T, et al. Role of chitinase-like proteins in cancer. Biol Chem. 2016;397(3):231–247.
  • Mitsuhashi A, Matsui H, Usui H, et al. Serum YKL-40 as a marker for cervical adenocarcinoma. Ann Oncol. 2009;20(1):71–77.
  • Brochner CB, Johansen JS, Larsen LA, et al. YKL-40 is differentially expressed in human embryonic stem cells and in cell progeny of the three germ layers. J Histochem Cytochem. 2012;60(3):188–204.
  • Johansen JS, Hoyer PE, Larsen LA, et al. YKL-40 protein expression in the early developing human musculoskeletal system. J Histochem Cytochem. 2007;55(12):1213–1228.
  • Rehli M, Krause SW, Andreesen R. Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation. Genomics. 1997;43(2):221–225.
  • Bussink AP, Speijer D, Aerts JM, et al. Evolution of mammalian chitinase(-like) members of family 18 glycosyl hydrolases. Genetics. 2007;177(2):959–970.
  • Faibish M, Francescone R, Bentley B, et al. A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers. Mol Cancer Ther. 2011;10(5):742–751.
  • Low D, Subramaniam R, Lin L, et al. Chitinase 3-like 1 induces survival and proliferation of intestinal epithelial cells during chronic inflammation and colitis-associated cancer by regulating S100A9. Oncotarget. 2015;6(34):36535–36550.
  • Lee CG, Da Silva CA, Dela Cruz CS, et al. Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu Rev Physiol. 2011;73:479–501.
  • Shao R, Hamel K, Petersen L, et al. YKL-40, a secreted glycoprotein, promotes tumor angiogenesis. Oncogene. 2009;28(50):4456–4468.
  • Lee CG, Hartl D, Lee GR, et al. Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis. J Exp Med. 2009;206(5):1149–1166.
  • Chen Y, Zhang S, Wang Q, et al. Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein. J Hematol Oncol. 2017;10(1):36.
  • Libreros S, Iragavarapu-Charyulu V. YKL-40/CHI3L1 drives inflammation on the road of tumor progression. J Leukoc Biol. 2015;98(6):931–936.
  • Libreros S, Garcia-Areas R, Shibata Y, et al. Induction of proinflammatory mediators by CHI3L1 is reduced by chitin treatment: decreased tumor metastasis in a breast cancer model. Int J Cancer. 2012;131(2):377–386.
  • Hamilton G, Rath B. Circulating tumor cell interactions with macrophages: implications for biology and treatment. Transl Lung Cancer Res. 2017;6(4):418–430.
  • Kim DH, Park HJ, Lim S, et al. Regulation of chitinase-3-like-1 in T cell elicits Th1 and cytotoxic responses to inhibit lung metastasis. Nat Commun. 2018;9(1):503.
  • Ngernyuang N, Francescone RA, Jearanaikoon P, et al. Chitinase 3 like 1 is associated with tumor angiogenesis in cervical cancer. Int J Biochem Cell Biol. 2014;51:45–52.
  • Ngernyuang N, Shao R, Suwannarurk K, et al. Chitinase 3 like 1 (CHI3L1) promotes vasculogenic mimicry formation in cervical cancer. Pathology. 2018;50(3):293–297.
  • http://dgcg.dk/images/retningslinier/Cervixcancer/DGC_retningslinier_for_cervix_revideret20jan2007.pdf. 2007
  • Bojesen SE, Johansen JS, Nordestgaard BG. Plasma YKL-40 levels in healthy subjects from the general population. Clin Chim Acta. 2011;412(9–10):709–712.
  • McShane LM, Altman DG, Sauerbrei W, et al. REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat. 2006;100(2):229–235.
  • Nielsen AR, Plomgaard P, Krabbe KS, et al. IL-6, but not TNF-alpha, increases plasma YKL-40 in human subjects. Cytokine. 2011;55(1):152–155.
  • Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012;21(3):309–322.
  • Lin YS, Liu YF, Chou YE, et al. Correlation of chitinase 3-like 1 single nucleotide polymorphisms and haplotypes with uterine cervical cancer in Taiwanese women. PLoS One. 2014;9(9):e104038.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.